Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study.

Lechevallier-Michel N, Molimard M, Dartigues JF, Fabrigoule C, Fourrier-Réglat A.

Br J Clin Pharmacol. 2005 Feb;59(2):143-51.

2.

Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study.

Uusvaara J, Pitkala KH, Tienari PJ, Kautiainen H, Tilvis RS, Strandberg TE.

J Am Geriatr Soc. 2009 Mar;57(3):427-31. doi: 10.1111/j.1532-5415.2008.02129.x.

PMID:
19278396
3.

Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study.

Carrière I, Fourrier-Reglat A, Dartigues JF, Rouaud O, Pasquier F, Ritchie K, Ancelin ML.

Arch Intern Med. 2009 Jul 27;169(14):1317-24. doi: 10.1001/archinternmed.2009.229.

4.

Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance.

Mulsant BH, Pollock BG, Kirshner M, Shen C, Dodge H, Ganguli M.

Arch Gen Psychiatry. 2003 Feb;60(2):198-203.

PMID:
12578438
5.

Breathing disorders during sleep and cognitive performance in an older community sample: the EVA Study.

Dealberto MJ, Pajot N, Courbon D, Alpérovitch A.

J Am Geriatr Soc. 1996 Nov;44(11):1287-94.

PMID:
8909342
6.

Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study.

Ehrt U, Broich K, Larsen JP, Ballard C, Aarsland D.

J Neurol Neurosurg Psychiatry. 2010 Feb;81(2):160-5. doi: 10.1136/jnnp.2009.186239. Epub 2009 Sep 21.

PMID:
19770163
7.

Detailed cognitive function and use of drugs with anticholinergic properties in older people: a community-based cross-sectional study.

Uusvaara J, Pitkala KH, Kautiainen H, Tilvis RS, Strandberg TE.

Drugs Aging. 2013 Mar;30(3):177-82. doi: 10.1007/s40266-013-0055-2.

PMID:
23361527
8.

Drugs with anticholinergic properties as a risk factor for cognitive impairment in elderly people: a population-based study.

Cancelli I, Gigli GL, Piani A, Zanchettin B, Janes F, Rinaldi A, Valente M.

J Clin Psychopharmacol. 2008 Dec;28(6):654-9. doi: 10.1097/JCP.0b013e31818ce849.

PMID:
19011434
9.

Effects of anticholinergic drugs on verbal episodic memory function in the elderly: a retrospective, cross-sectional study.

Fortin MP, Rouch I, Dauphinot V, Gédéon C, Genthon S, Bonnefoy M, Krolak-Salmon P.

Drugs Aging. 2011 Mar 1;28(3):195-204. doi: 10.2165/11586580-000000000-00000.

PMID:
21329401
10.

Anticholinergic drugs and physical function among frail elderly population.

Landi F, Russo A, Liperoti R, Cesari M, Barillaro C, Pahor M, Bernabei R, Onder G.

Clin Pharmacol Ther. 2007 Feb;81(2):235-41. Epub 2006 Dec 27.

PMID:
17192773
11.

Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes.

Kersten H, Molden E, Willumsen T, Engedal K, Bruun Wyller T.

Br J Clin Pharmacol. 2013 Mar;75(3):842-9. doi: 10.1111/j.1365-2125.2012.04411.x. Erratum in: Br J Clin Pharmacol. 2013 Apr;75(4):1171-2.

12.

Use of medications with anticholinergic properties and cognitive function in a young-old community sample.

Low LF, Anstey KJ, Sachdev P.

Int J Geriatr Psychiatry. 2009 Jun;24(6):578-84. doi: 10.1002/gps.2157.

PMID:
19021151
13.

[The estimation of premorbid intelligence levels in French speakers].

Mackinnon A, Mulligan R.

Encephale. 2005 Jan-Feb;31(1 Pt 1):31-43. French.

PMID:
15971638
14.

Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study.

Fox C, Richardson K, Maidment ID, Savva GM, Matthews FE, Smithard D, Coulton S, Katona C, Boustani MA, Brayne C.

J Am Geriatr Soc. 2011 Aug;59(8):1477-83. doi: 10.1111/j.1532-5415.2011.03491.x. Epub 2011 Jun 24.

PMID:
21707557
15.

Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study.

Pasina L, Djade CD, Lucca U, Nobili A, Tettamanti M, Franchi C, Salerno F, Corrao S, Marengoni A, Iorio A, Marcucci M, Violi F, Mannucci PM.

Drugs Aging. 2013 Feb;30(2):103-12. doi: 10.1007/s40266-012-0044-x.

PMID:
23239364
16.

A cross-sectional and longitudinal study of the relationship between walking speed and cognitive function in community-dwelling elderly people.

Soumaré A, Tavernier B, Alpérovitch A, Tzourio C, Elbaz A.

J Gerontol A Biol Sci Med Sci. 2009 Oct;64(10):1058-65. doi: 10.1093/gerona/glp077. Epub 2009 Jun 26.

PMID:
19561146
17.

Adherence to a Mediterranean diet, cognitive decline, and risk of dementia.

Féart C, Samieri C, Rondeau V, Amieva H, Portet F, Dartigues JF, Scarmeas N, Barberger-Gateau P.

JAMA. 2009 Aug 12;302(6):638-48. doi: 10.1001/jama.2009.1146. Erratum in: JAMA. 2009 Dec 9;302(22):2436.

18.

[Longitudinal study of cognitive aging in non-demented elderly subjects].

Jacqmin-Gadda H, Fabrigoule C, Commenges D, Dartigues JF.

Rev Epidemiol Sante Publique. 1997 Oct;45(5):363-72. French.

PMID:
9446142
19.

Anticholinergic drugs and functional outcomes in older patients undergoing orthopaedic rehabilitation.

Koshoedo S, Soiza RL, Purkayastha R, Mangoni AA.

Am J Geriatr Pharmacother. 2012 Aug;10(4):251-7. doi: 10.1016/j.amjopharm.2012.06.003. Epub 2012 Jul 13.

PMID:
22795433
20.

Prevalence and predictors of anticholinergic agents in elderly outpatients with dementia.

Bhattacharya R, Chatterjee S, Carnahan RM, Aparasu RR.

Am J Geriatr Pharmacother. 2011 Dec;9(6):434-41. doi: 10.1016/j.amjopharm.2011.10.001. Epub 2011 Oct 26.

PMID:
22030114

Supplemental Content

Support Center